South Korea · Delayed Price · Currency is KRW Sam-A Pharm. Statistics
Total Valuation
Sam-A Pharm. has a market cap or net worth of KRW 99.67 billion. The enterprise value is 17.17 billion.
| Market Cap | 99.67B |
| Enterprise Value | 17.17B |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Sam-A Pharm. has 6.10 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 6.10M |
| Shares Outstanding | 6.10M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -3.09% |
| Owned by Insiders (%) | 68.45% |
| Owned by Institutions (%) | n/a |
| Float | 1.93M |
Valuation Ratios
The trailing PE ratio is 7.56.
| PE Ratio | 7.56 |
| Forward PE | n/a |
| PS Ratio | 1.30 |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.45 |
| P/FCF Ratio | 10.78 |
| P/OCF Ratio | 8.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.10, with an EV/FCF ratio of 1.86.
| EV / Earnings | 1.30 |
| EV / Sales | 0.22 |
| EV / EBITDA | 1.10 |
| EV / EBIT | 1.57 |
| EV / FCF | 1.86 |
Financial Position
The company has a current ratio of 7.79, with a Debt / Equity ratio of 0.04.
| Current Ratio | 7.79 |
| Quick Ratio | 6.62 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | 0.91 |
| Interest Coverage | 22.68 |
Financial Efficiency
Return on equity (ROE) is 6.02% and return on invested capital (ROIC) is 3.33%.
| Return on Equity (ROE) | 6.02% |
| Return on Assets (ROA) | 3.11% |
| Return on Invested Capital (ROIC) | 3.33% |
| Return on Capital Employed (ROCE) | 5.31% |
| Revenue Per Employee | 251.34M |
| Profits Per Employee | 43.23M |
| Employee Count | 305 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.88 |
Taxes
In the past 12 months, Sam-A Pharm. has paid 3.72 billion in taxes.
| Income Tax | 3.72B |
| Effective Tax Rate | 22.00% |
Stock Price Statistics
The stock price has decreased by -3.43% in the last 52 weeks. The beta is 0.16, so Sam-A Pharm.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -3.43% |
| 50-Day Moving Average | 16,669.00 |
| 200-Day Moving Average | 16,991.40 |
| Relative Strength Index (RSI) | 44.77 |
| Average Volume (20 Days) | 9,044 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sam-A Pharm. had revenue of KRW 76.66 billion and earned 13.19 billion in profits. Earnings per share was 2,160.73.
| Revenue | 76.66B |
| Gross Profit | 46.77B |
| Operating Income | 12.21B |
| Pretax Income | 16.91B |
| Net Income | 13.19B |
| EBITDA | 16.92B |
| EBIT | 12.21B |
| Earnings Per Share (EPS) | 2,160.73 |
Balance Sheet
The company has 90.90 billion in cash and 8.41 billion in debt, giving a net cash position of 82.50 billion or 13,516.66 per share.
| Cash & Cash Equivalents | 90.90B |
| Total Debt | 8.41B |
| Net Cash | 82.50B |
| Net Cash Per Share | 13,516.66 |
| Equity (Book Value) | 224.41B |
| Book Value Per Share | 37,356.57 |
| Working Capital | 110.74B |
Cash Flow
In the last 12 months, operating cash flow was 11.62 billion and capital expenditures -2.37 billion, giving a free cash flow of 9.25 billion.
| Operating Cash Flow | 11.62B |
| Capital Expenditures | -2.37B |
| Free Cash Flow | 9.25B |
| FCF Per Share | 1,514.96 |
Margins
Gross margin is 61.01%, with operating and profit margins of 15.92% and 17.20%.
| Gross Margin | 61.01% |
| Operating Margin | 15.92% |
| Pretax Margin | 22.05% |
| Profit Margin | 17.20% |
| EBITDA Margin | 22.07% |
| EBIT Margin | 15.92% |
| FCF Margin | 12.06% |
Dividends & Yields
This stock pays an annual dividend of 800.00, which amounts to a dividend yield of 4.91%.
| Dividend Per Share | 800.00 |
| Dividend Yield | 4.91% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 37.03% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 4.90% |
| Earnings Yield | 13.23% |
| FCF Yield | 9.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 29, 2008. It was a forward split with a ratio of 1.02005.
| Last Split Date | Dec 29, 2008 |
| Split Type | Forward |
| Split Ratio | 1.02005 |
Scores
Sam-A Pharm. has an Altman Z-Score of 5.12 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.12 |
| Piotroski F-Score | 4 |